Long-term results of guided tissue regeneration therapy with non-resorbable and bioabsorbable barriers. III. Class II furcations after 10 years

被引:46
|
作者
Eickholz, Peter
Pretzl, Bernadette
Holle, Rolf
Kim, Ti-Sun
机构
[1] Univ Hosp Frankfurt, Ctr Dent Oral & Maxillofacial Med, Dept Periodontol, Frankfurt, Germany
[2] Univ Hosp Heidelberg, Ctr Dent Oral & Maxillofacial Med, Dept Conservat Dent, Sect Periodontol, Heidelberg, Germany
[3] GSF Natl Res, Ctr Environm & Hlth, Inst Hlth Econ & Hlth Care Management, Neuherberg, Germany
关键词
furcation defects/therapy; guided tissue regeneration; membranes; artificial; polytetrafluoroethylene/therapeutic use;
D O I
10.1902/jop.2006.77.1.88
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Background: The aim of this 10-year follow-up was to evaluate the long-term results after guided tissue regeneration (GTR) therapy of Class II furcation defects using non-resorbable and bioabsorbable barriers clinically. Methods: In nine patients with advanced periodontitis, nine pairs of contralateral Class 11 furcation defects were treated. Within each patient, one defect received a non-resorbable expanded polytetrafluoroethylene barrier (ePTFE; C) and the other a bioabsorbable (polyglactin 910; T) barrier by random assignment. At baseline and 12 and 120 6 months after surgery, clinical parameters were obtained. Results: Twelve and 120 months after GTR therapy, statistically significant (P < 0.05) horizontal clinical attachment level (CAL-H) gain was observed in both groups (C12: 1.9 +/- 0.5 mm; C120: 1.1 +/- 1.3 mm; T12: 1.9 +/- 0.8 mm; T120: 1.7 +/- 1.4 mm). However, one patient with furcations that had been assessed as Class 1 12 months after GTR therapy had lost two teeth after 10 years, and another patient had lost more than 2 mm CAL-H at one furcation from 12 to 120 6 months post-surgery 10 years after implantation of an ePTFE barrier. Horizontal bone sounding revealed similar bone gain in both groups 120 6 months post-surgery (C120: 0.8 1.0 mm; T120: 1.1 1.1 mm). Conclusions: CAL-H gain achieved after GTR therapy in Class 11 furcations was stable after 10 years in 15 of 18 defects (83%). The study failed to show a statistically significant difference in stability of CAL-H gain between group C and T 10 years after GTR therapy.
引用
收藏
页码:88 / 94
页数:7
相关论文
共 31 条
  • [21] Re: Long-Term (&gt; 10 Years) Results after Endoscopic Injection Therapy for Vesicoureteral Reflux
    Canning, Douglas A.
    JOURNAL OF UROLOGY, 2019, 201 (05): : 846 - 846
  • [22] Long-term stability of periodontal conditions achieved following guided tissue regeneration with bioresorbable membranes: case series results after 6-7 years
    Stavropoulos, A
    Karring, T
    JOURNAL OF CLINICAL PERIODONTOLOGY, 2004, 31 (11) : 939 - 944
  • [23] Marginal soft tissue recession after lateral guided bone regeneration at implant site: A long-term study with at least 5 years of loading
    Cairo, Francesco
    Nieri, Michele
    Cavalcanti, Raffaele
    Landi, Luca
    Rupe, Antonio
    Sforza, Nicola Marco
    Pace, Riccardo
    Barbato, Luigi
    CLINICAL ORAL IMPLANTS RESEARCH, 2020, 31 (11) : 1116 - 1124
  • [24] Long-term outcomes after proton therapy, with concurrent chemotherapy, for stage II-III inoperable non-small cell lung cancer
    Quynh-Nhu Nguyen
    Ngoc Bui Ly
    Komaki, Ritsuko
    Levy, Lawrence B.
    Gomez, Daniel R.
    Chang, Joe Y.
    Allen, Pamela K.
    Mehran, Reza J.
    Lu, Charles
    Gillin, Michael
    Liao, Zhongxing
    Cox, James D.
    RADIOTHERAPY AND ONCOLOGY, 2015, 115 (03) : 367 - 372
  • [25] Retrospectively analysed tooth loss in periodontally compromised patients: Long-term results 10 years after active periodontal therapy-Patient-related outcomes
    Petsos, Hari
    Schacher, Beate
    Ramich, Tatjana
    Nickles, Katrin
    Dannewitz, Bettina
    Arendt, Susanne
    Seidel, Kathrin
    Eickholz, Peter
    JOURNAL OF PERIODONTAL RESEARCH, 2020, 55 (06) : 946 - 958
  • [26] Tooth loss in periodontally compromised patients: Retrospective long-term results 10 years after active periodontal therapy. Tooth-related outcomes
    Petsos, Hari
    Ramich, Tatjana
    Nickles, Katrin
    Dannewitz, Bettina
    Pfeifer, Leon
    Zuhr, Otto
    Eickholz, Peter
    JOURNAL OF PERIODONTOLOGY, 2021, 92 (12) : 1761 - 1775
  • [27] LONG-TERM RESULTS OF A PHASE II STUDY OF COMBINED MODALITY THERAPY WITH CONCURRENT RADIATION THERAPY PLUS DOCETAXEL AND CARBOPLATIN FOR UNRESECTABLE STAGE III NON-SMALL-CELL-LUNG CANCER
    Gauden, Ruth E.
    Haug, Greg
    Markos, James
    Parkes, Scott
    Gauden, Stan
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1570 - S1571
  • [28] 10 Years Experience with Maastricht Category III Donation After Circulatory Death (DCD) in Lung Transplantation (LTx) - Analysis of Early and Long-Term Results in Large Single-Centre Cohort
    Zych, B.
    Garcia-Saez, D.
    Ananiadou, O.
    Mohite, P. N.
    Fazekas, L.
    Husain, M.
    Schmack, B.
    De Robertis, E.
    Popov, A. F.
    Bahrami, T.
    Marczin, N.
    Reed, A.
    Carby, M.
    Simon, A. R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2017, 36 (04): : S144 - S144
  • [29] Struggle for (Graft-) Survival: Long-Term Results Comparing Standard Therapy With Tacrolimus/Mycophenolate Mofetil Versus De-Novo Low-Dose Tacrolimus/Sirolimus Therapy 10 Years After Heart Transplantation
    Guethoff, S.
    Stroeh, K.
    Koenig, M.
    Meiser, B. M.
    Zaruba, M.
    Grinninger, C.
    Reichart, B.
    Ueberfuhr, P.
    Hagl, C.
    Kaczmarek, I.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S134 - S134
  • [30] Long-Term Results from the IDEAL-CRT Phase 1/2 Trial of Isotoxically Dose-Escalated Radiation Therapy and Concurrent Chemotherapy for Stage II/III Non-small Cell Lung Cancer
    Fenwick, John D.
    Landau, David B.
    Baker, Angela T.
    Bates, Andrew T.
    Eswar, Chinnamani
    Garcia-Alonso, Angel
    Harden, Susan V.
    Illsley, Marianne C.
    Laurence, Virginia
    Malik, Zafar
    Mayles, William Philip M.
    Miles, Elizabeth
    Mohammed, Nazia
    Spicer, James
    Wells, Paula
    Vivekanandan, Sindu
    Mullin, Anne-Marie
    Hughes, Laura
    Farrelly, Laura
    Ngai, Yenting
    Counsell, Nicholas
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 106 (04): : 733 - 742